Literature DB >> 17661759

The clinical needs of patients with chronic gastrointestinal symptoms after pelvic radiotherapy.

C Gillespie1, C Goode, C Hackett, H J N Andreyev.   

Abstract

BACKGROUND: After radiotherapy for pelvic cancer, gastrointestinal symptoms affecting quality of life are common. How they affect daily living is unknown. AIM: To investigate the day-to-day impact of gastrointestinal symptoms in patients after pelvic radiotherapy.
METHODS: New patients referred for gastroenterological evaluation of radiotherapy-induced symptoms were sent a questionnaire.
RESULTS: Over 15 months, 75 of 100 questionnaires were completed before the gastroenterology appointment by 45 men (median age 70) and 30 women (median age 57) treated for urological (n = 44), gynaecological (n = 27) and gastrointestinal (n = 4) cancers. Time since radiotherapy was 3 years (median) for women and 1.5 years (men). Women experienced 6 (median) symptoms whilst men experienced 4. Having someone listen to problems was often as important as treatment. Urgency, diarrhoea, pain, rectal bleeding, flatulence and bloating were particularly troublesome. 57% women and 33% men were 'very affected'. Symptoms rarely improved with time and in 33% had been present for more than 2 years. Gastrointestinal symptoms affected quality of life through change of routine (F 37%, M 22%), social limitation (F 17%, M 33%), physical limitations (F 33%, M 16%), emotional difficulties (F 47%, M 18%) and sexual problems (F 30%, M 51%).
CONCLUSIONS: Patients experience a high number of physical symptoms for long periods before referral. Clinicians must focus systematically on physical, emotional and psychosexual issues.

Entities:  

Mesh:

Year:  2007        PMID: 17661759     DOI: 10.1111/j.1365-2036.2007.03405.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

1.  Targeting precision medicine toxicity: recent developments.

Authors:  Gordon Mallarkey; Arduino A Mangoni
Journal:  Ther Adv Drug Saf       Date:  2015-02

2.  Effect on prostate volume following neoadjuvant treatment with an androgen receptor inhibitor monotherapy versus castration plus an androgen receptor inhibitor in prostate cancer patients intended for curative radiation therapy: A randomised study.

Authors:  Khairul Majumder; Yvonne Brandberg; Hemming Johansson; Enrique Castellanos; Anders Ullén; Bo Lennernäs; Sten Nilsson
Journal:  Mol Clin Oncol       Date:  2017-11-03

Review 3.  Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists.

Authors:  Ann C Muls; Lorraine Watson; Clare Shaw; H Jervoise N Andreyev
Journal:  Frontline Gastroenterol       Date:  2012-10-02

4.  Outcomes from treating bile acid malabsorption using a multidisciplinary approach.

Authors:  Ankur Gupta; Ann C Muls; Amyn Lalji; Karen Thomas; Lorraine Watson; Clare Shaw; H Jervoise N Andreyev
Journal:  Support Care Cancer       Date:  2015-02-20       Impact factor: 3.603

5.  Cancer-related psychosocial factors and self-reported changes in lifestyle among gynecological cancer survivors: cross-sectional analysis of PROFILES registry data.

Authors:  Karin A J Driessen; Belle H de Rooij; M Caroline Vos; Dorry Boll; Johanna M A Pijnenborg; Meeke Hoedjes; Sandra Beijer; Nicole P M Ezendam
Journal:  Support Care Cancer       Date:  2021-08-28       Impact factor: 3.359

6.  Perception of body odor-an overlooked consequence of long-term gastrointestinal and urinary symptoms after radiation therapy for prostate cancer.

Authors:  D Alsadius; C Olsson; N Pettersson; S L Tucker; U Wilderäng; G Steineck
Journal:  J Cancer Surviv       Date:  2013-08-23       Impact factor: 4.442

Review 7.  Chronic radiation proctitis: tricks to prevent and treat.

Authors:  Ben G L Vanneste; Lien Van De Voorde; Rogier J de Ridder; Evert J Van Limbergen; Philippe Lambin; Emile N van Lin
Journal:  Int J Colorectal Dis       Date:  2015-07-23       Impact factor: 2.571

8.  Gastroenterologist and nurse management of symptoms after pelvic radiotherapy for cancer: an economic evaluation of a clinical randomized controlled trial (the ORBIT study).

Authors:  Jake Jordan; Heather Gage; Barbara Benton; Amyn Lalji; Christine Norton; H Jervoise N Andreyev
Journal:  Clinicoecon Outcomes Res       Date:  2017-04-28

9.  A proposed tailored investigational algorithm for women treated for gynaecological cancer with long-term gastrointestinal consequences.

Authors:  Ann Muls; Alexandra Taylor; Susan Lalondrelle; Mohammed Kabir; Christine Norton; Ailsa Hart; H Jervoise Andreyev
Journal:  Support Care Cancer       Date:  2020-01-29       Impact factor: 3.603

10.  The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy.

Authors:  H Jervoise N Andreyev; Amyn Lalji; Kabir Mohammed; Ann C G Muls; David Watkins; Sheela Rao; Naureen Starling; Ian Chau; Sarah Cruse; Ville Pitkaaho; Jennifer Matthews; Laura Caley; Victoria Pittordou; Carolyn Adams; Linda Wedlake
Journal:  Support Care Cancer       Date:  2020-07-16       Impact factor: 3.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.